Analysts’ price target changes for Wednesday, May 6th:
AdaptHealth (NASDAQ:AHCO) had its target price trimmed by UBS Group AG from $15.00 to $14.00. The firm currently has a buy rating on the stock.
Alphatec (NASDAQ:ATEC) had its target price reduced by JPMorgan Chase & Co. from $24.00 to $16.00. JPMorgan Chase & Co. currently has an overweight rating on the stock.
Brookfield Asset Management (NYSE:BAM) (TSE:BAM.A) had its price target trimmed by JPMorgan Chase & Co. from $72.00 to $60.00. JPMorgan Chase & Co. currently has a neutral rating on the stock.
Bright Horizons Family Solutions (NYSE:BFAM) had its price target trimmed by JPMorgan Chase & Co. from $115.00 to $105.00. The firm currently has an overweight rating on the stock.
Bright Horizons Family Solutions (NYSE:BFAM) had its target price trimmed by UBS Group AG from $93.00 to $88.00. They currently have a neutral rating on the stock.
Bumble (NASDAQ:BMBL) had its price target boosted by UBS Group AG from $4.00 to $4.50. They currently have a neutral rating on the stock.
BellRing Brands (NYSE:BRBR) had its price target lowered by JPMorgan Chase & Co. from $21.00 to $13.00. They currently have an overweight rating on the stock.
BellRing Brands (NYSE:BRBR) had its target price reduced by UBS Group AG from $19.00 to $12.00. They currently have a neutral rating on the stock.
Peabody Energy (NYSE:BTU) had its target price lowered by UBS Group AG from $32.00 to $30.50. The firm currently has a neutral rating on the stock.
Choice Hotels International (NYSE:CHH) had its target price cut by JPMorgan Chase & Co. from $117.00 to $116.00. They currently have a neutral rating on the stock.
DuPont de Nemours (NYSE:DD) had its price target raised by UBS Group AG from $56.00 to $59.00. UBS Group AG currently has a buy rating on the stock.
DigitalOcean (NYSE:DOCN) had its price target raised by UBS Group AG from $105.00 to $160.00. They currently have a neutral rating on the stock.
Enlight Renewable Energy (NASDAQ:ENLT) had its price target increased by UBS Group AG from $93.00 to $105.00. The firm currently has a buy rating on the stock.
Energizer (NYSE:ENR) had its price target lowered by JPMorgan Chase & Co. from $21.00 to $19.00. JPMorgan Chase & Co. currently has a neutral rating on the stock.
Intapp (NASDAQ:INTA) had its target price lowered by JPMorgan Chase & Co. from $58.00 to $47.00. They currently have an overweight rating on the stock.
KKR & Co. Inc. (NYSE:KKR) had its target price boosted by UBS Group AG from $113.00 to $126.00. They currently have a buy rating on the stock.
Lumen Technologies (NYSE:LUMN) had its price target boosted by UBS Group AG from $6.00 to $8.00. They currently have a neutral rating on the stock.
Mohawk Industries (NYSE:MHK) had its target price trimmed by JPMorgan Chase & Co. from $143.00 to $138.00. JPMorgan Chase & Co. currently has an overweight rating on the stock.
Procore Technologies (NYSE:PCOR) had its target price trimmed by UBS Group AG from $74.00 to $68.00. UBS Group AG currently has a buy rating on the stock.
Qualys (NASDAQ:QLYS) had its target price reduced by JPMorgan Chase & Co. from $113.00 to $87.00. They currently have an underweight rating on the stock.
Repligen (NASDAQ:RGEN) had its price target lowered by JPMorgan Chase & Co. from $180.00 to $165.00. They currently have an overweight rating on the stock.
Revvity (NYSE:RVTY) had its target price lowered by JPMorgan Chase & Co. from $96.00 to $90.00. The firm currently has a neutral rating on the stock.
Silver Standard Resources (NASDAQ:SSRM) (TSE:SSO) had its target price increased by UBS Group AG from $43.00 to $44.00. The firm currently has a buy rating on the stock.
Skyworks Solutions (NASDAQ:SWKS) had its target price raised by UBS Group AG from $63.00 to $75.00. The firm currently has a neutral rating on the stock.
Transdigm Group (NYSE:TDG) had its target price trimmed by UBS Group AG from $1,745.00 to $1,645.00. The firm currently has a buy rating on the stock.
Waters (NYSE:WAT) had its target price raised by JPMorgan Chase & Co. from $330.00 to $345.00. They currently have a neutral rating on the stock.
Receive News & Ratings for AdaptHealth Corp Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for AdaptHealth Corp and related companies with MarketBeat.com's FREE daily email newsletter.
